Parameters | Intervention group (n = 120) | Control group (n = 100) | ||
---|---|---|---|---|
Completers (n = 93) | Dropouts (n = 27) | Completers (n = 83) | Dropouts (n = 17) | |
Sex (male/female) [n] | 42 / 51 (45% / 55%) | 13 / 14 (48% / 52%) | 35 / 48 (42% / 58%) | 11 / 6 (65% / 35%) |
Age [years] | 61 ± 7 | 61 ± 9 | 60 ± 8 | 63 ± 7 |
Weight [kg] | 97 ± 19 | 98 ± 21 | 97 ± 23 | 92 ± 13 |
Body mass index [kg/m2] | 33.9 ± 6.4 | 34.4 ± 7.1 | 33.5 ± 6.5 | 31.7 ± 4.6 |
Systolic blood pressure [mmHg] | 134 ± 15 | 135 ± 13 | 134 ± 17 | 138 ± 17 |
Diastolic blood pressure [mmHg] | 79 ± 8 | 81 ± 9 | 80 ± 10 | 80 ± 5 |
Fasting blood glucose [mg/dl] | 134 ± 38 | 141 ± 41 | 133 ± 40 | 118 ± 26 |
Total cholesterol [mg/dl] | 207 ± 42 | 207 ± 45 | 203 ± 47 | 198 ± 38 |
HDL cholesterol [mg/dl] | 50 ± 14 | 49 ± 8 | 48 ± 11 | 46 ± 9 |
LDL cholesterol [mg/dl] | 125 ± 34 | 128 ± 31 | 124 ± 48 | 123 ± 37 |
Triglycerides [mg/dl] | 209 ± 128 | 179 ± 84 | 243 ± 257 | 188 ± 70 |
Physical activity [%] | 42 ± 18 | 40 ± 23 | 41 ± 19 | 52 ± 28 |
Treatment with Metformin [%] | 77 | 59 | 78 | 76 |
Treatment with DPP-4 inhibitors [%] | 14 | 22 | 19 | 18 |